1. Please check and comment entries here.
Table of Contents

    Topic review

    Loeys-Dietz Syndrome

    View times: 18
    Submitted by: Camila Xu
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    Loeys-Dietz syndrome is a disorder that affects the connective tissue in many parts of the body. Connective tissue provides strength and flexibility to structures such as bones, ligaments, muscles, and blood vessels.

    1. Introduction

    There are five types of Loeys-Dietz syndrome, labelled types I through V, which are distinguished by their genetic cause. Regardless of the type, signs and symptoms of Loeys-Dietz syndrome can become apparent anytime from childhood through adulthood, and the severity is variable.

    Loeys-Dietz syndrome is characterized by enlargement of the aorta, which is the large blood vessel that distributes blood from the heart to the rest of the body. The aorta can weaken and stretch, causing a bulge in the blood vessel wall (an aneurysm). Stretching of the aorta may also lead to a sudden tearing of the layers in the aorta wall (aortic dissection). People with Loeys-Dietz syndrome can also have aneurysms or dissections in arteries throughout the body and have arteries with abnormal twists and turns (arterial tortuosity).

    Individuals with Loeys-Dietz syndrome often have skeletal problems including premature fusion of the skull bones (craniosynostosis), an abnormal side-to-side curvature of the spine (scoliosis), either a sunken chest (pectus excavatum) or a protruding chest (pectus carinatum), an inward- and upward-turning foot (clubfoot), flat feet (pes planus), or elongated limbs with joint deformities called contractures that restrict the movement of certain joints. A membrane called the dura, which surrounds the brain and spinal cord, can be abnormally enlarged (dural ectasia). In individuals with Loeys-Dietz syndrome, dural ectasia typically does not cause health problems. Malformation or instability of the spinal bones (vertebrae) in the neck is a common feature of Loeys-Dietz syndrome and can lead to injuries to the spinal cord. Some affected individuals have joint inflammation (osteoarthritis) that commonly affects the knees and the joints of the hands, wrists, and spine.

    People with Loeys-Dietz syndrome may bruise easily and develop abnormal scars after wound healing. The skin is frequently described as translucent, often with stretch marks (striae) and visible underlying veins. Some individuals with Loeys-Dietz syndrome develop an abnormal accumulation of air in the chest cavity that can result in the collapse of a lung (spontaneous pneumothorax) or a protrusion of organs through gaps in muscles (hernias). Other characteristic features include widely spaced eyes (hypertelorism), eyes that do not point in the same direction (strabismus), a split in the soft flap of tissue that hangs from the back of the mouth (bifid uvula), and an opening in the roof of the mouth (cleft palate).

    Individuals with Loeys-Dietz syndrome frequently develop immune system-related problems such as food allergies, asthma, or inflammatory disorders such as eczema or inflammatory bowel disease.

    2. Frequency

    The prevalence of Loeys-Dietz syndrome is unknown. Loeys-Dietz syndrome types I and II appear to be the most common forms.

    3. Causes

    The five types of Loeys-Dietz syndrome are distinguished by their genetic cause: TGFBR1 gene mutations cause type I, TGFBR2 gene mutations cause type II, SMAD3 gene mutations cause type III, TGFB2 gene mutations cause type IV, and TGFB3 gene mutations cause type V. These five genes play roles in a cell signaling pathway called the transforming growth factor beta (TGF-β) pathway, which directs the functions of the body's cells during growth and development. This pathway also regulates the formation of the extracellular matrix, an intricate lattice of proteins and other molecules that forms in the spaces between cells and is important for tissue strength and repair.

    Mutations in the TGFBR1, TGFBR2, SMAD3, TGFB2, or TGFB3 gene result in the production of a protein with reduced function. Even though the protein is less active, signaling within the TGF-β pathway occurs at an even greater intensity than normal in tissues throughout the body. Researchers speculate that the activity of other proteins in this signaling pathway is increased to compensate for the protein whose function is reduced; however, the exact mechanism responsible for the increase in signaling is unclear. The overactive TGF-β pathway disrupts the development of the extracellular matrix and various body systems, leading to the signs and symptoms of Loeys-Dietz syndrome.

    4. Inheritance

    Loeys-Dietz syndrome has an autosomal dominant pattern of inheritance, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

    In about 75 percent of cases, this disorder results from a new gene mutation and occurs in people with no history of the disorder in their family. In other cases, an affected person inherits the mutation from one affected parent.

    5. Other Names for This Condition

    • LDS

    • Loeys-Dietz aortic aneurysm syndrome

    This entry is adapted from https://medlineplus.gov/genetics/condition/loeys-dietz-syndrome

    References

    1. Arslan-Kirchner M, Epplen JT, Faivre L, Jondeau G, Schmidtke J, De Paepe A,Loeys B. Clinical utility gene card for: Loeys-Dietz syndrome (TGFBR1/2) andrelated phenotypes. Eur J Hum Genet. 2011 Oct;19(10). doi: 10.1038/ejhg.2011.68.
    2. Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JMA, de Graaf BM, van deBeek G, Gallo E, Kruithof BPT, Venselaar H, Myers LA, Laga S, Doyle AJ, Oswald G,van Cappellen GWA, Yamanaka I, van der Helm RM, Beverloo B, de Klein A, Pardo L, Lammens M, Evers C, Devriendt K, Dumoulein M, Timmermans J, Bruggenwirth HT,Verheijen F, Rodrigus I, Baynam G, Kempers M, Saenen J, Van Craenenbroeck EM,Minatoya K, Matsukawa R, Tsukube T, Kubo N, Hofstra R, Goumans MJ, Bekkers JA,Roos-Hesselink JW, van de Laar IMBH, Dietz HC, Van Laer L, Morisaki T, WesselsMW, Loeys BL. Mutations in a TGF-β ligand, TGFB3, cause syndromic aorticaneurysms and dissections. J Am Coll Cardiol. 2015 Apr 7;65(13):1324-1336. doi:10.1016/j.jacc.2015.01.040.
    3. Boodhwani M, Andelfinger G, Leipsic J, Lindsay T, McMurtry MS, Therrien J, SiuSC; Canadian Cardiovascular Society. Canadian Cardiovascular Society positionstatement on the management of thoracic aortic disease. Can J Cardiol. 2014Jun;30(6):577-89. doi: 10.1016/j.cjca.2014.02.018.
    4. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H,Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B,Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA,Allmen RS, Vrints CJ; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute andchronic aortic diseases of the thoracic and abdominal aorta of the adult. TheTask Force for the Diagnosis and Treatment of Aortic Diseases of the EuropeanSociety of Cardiology (ESC). Eur Heart J. 2014 Nov 1;35(41):2873-926. doi:10.1093/eurheartj/ehu281.1;36(41):2779.
    5. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L,Halushka MK, Oliva-Hemker M, Wood RA, Dietz HC. TGFβ receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med. 2013 Jul24;5(195):195ra94. doi: 10.1126/scitranslmed.3006448.
    6. Kalra VB, Gilbert JW, Malhotra A. Loeys-Dietz syndrome: cardiovascular,neuroradiological and musculoskeletal imaging findings. Pediatr Radiol. 2011Dec;41(12):1495-504; quiz 1616. doi: 10.1007/s00247-011-2195-z.Review.
    7. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ,Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM,Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, BrunnerHG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL. Loss-of-functionmutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.Nat Genet. 2012 Jul 8;44(8):922-7. doi: 10.1038/ng.2349.
    8. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF,Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, PyeritzRE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM,Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N EnglJ Med. 2006 Aug 24;355(8):788-98.
    9. Luo M, Yang H, Yin K, Chen Q, Zhang J, Fan Y, Zhou Z, Chang Q. Genetic testingof 10 patients with features of Loeys-Dietz syndrome. Clin Chim Acta. 2016 May1;456:144-148. doi: 10.1016/j.cca.2016.02.005.
    10. MacCarrick G, Black JH 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HC 3rd. Loeys-Dietz syndrome: aprimer for diagnosis and management. Genet Med. 2014 Aug;16(8):576-87. doi:10.1038/gim.2014.11.
    11. Teixidó-Tura G, Franken R, Galuppo V, Gutiérrez García-Moreno L, Borregan M,Mulder BJ, García-Dorado D, Evangelista A. Heterogeneity of aortic diseaseseverity in patients with Loeys-Dietz syndrome. Heart. 2016 Apr;102(8):626-32.doi: 10.1136/heartjnl-2015-308535.
    12. van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-ZeinstraSM, van Meer BL, Pals G, Oldenburg RA, Bekkers JA, Moelker A, de Graaf BM, MatyasG, Frohn-Mulder IM, Timmermans J, Hilhorst-Hofstee Y, Cobben JM, Bruggenwirth HT,van Laer L, Loeys B, De Backer J, Coucke PJ, Dietz HC, Willems PJ, Oostra BA, De Paepe A, Roos-Hesselink JW, Bertoli-Avella AM, Wessels MW. Phenotypic spectrum ofthe SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet. 2012Jan;49(1):47-57. doi: 10.1136/jmedgenet-2011-100382.
    13. Van Hemelrijk C, Renard M, Loeys B. The Loeys-Dietz syndrome: an update forthe clinician. Curr Opin Cardiol. 2010 Nov;25(6):546-51. doi:10.1097/HCO.0b013e32833f0220. Review.
    14. Verhagen JMA, Kempers M, Cozijnsen L, Bouma BJ, Duijnhouwer AL, Post JG,Hilhorst-Hofstee Y, Bekkers SCAM, Kerstjens-Frederikse WS, van Brakel TJ,Lambermon E, Wessels MW, Loeys BL, Roos-Hesselink JW, van de Laar IMBH; National Working Group on BAV & TAA. Expert consensus recommendations on the cardiogeneticcare for patients with thoracic aortic disease and their first-degree relatives. Int J Cardiol. 2018 May 1;258:243-248. doi: 10.1016/j.ijcard.2018.01.145.
    More